Siemens Aktiengesellschaft · XETR:SIE
Siemens Aktiengesellschaft — Siemens — Investor Day (September 2009)
26 slides from Siemens Aktiengesellschaft's investor day presentation, Sep 29, 2009
Slide 1: Siemens Healthcare Global Presence, Regional Focus
Siemens Healthcare Global Presence, Regional Focus Thomas Miller CEO Workflow & Solutions Division Capital Market Day Siemens Healthcare London, September 29, 2009 © Siemens AG 2009. All rights reserved.
Slide 2: Safe Harbour Statement
Safe Harbour Statement This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified by words such as “expects,” “looks forward to,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,”
Slide 3: Global Presence, Regional Focus
Global Presence, Regional Focus U.S. Healthcare Environment Opportunities in China © Siemens AG 2009. All rights reserved. Page 3 Sept. 29, 2009 Capital Market Day Healthcare Healthcare Workflow & Solutions
Slide 4: Well positioned in a challenging market environment
Well positioned in a challenging market environment U.S. Healthcare Environment © Siemens AG 2009. All rights reserved. Page 4 Sept. 29, 2009 Capital Market Day Healthcare Healthcare Workflow & Solutions
Slide 5: Executive summary of U.S. healthcare reform and its impact on our business
Executive summary of U.S. healthcare reform and its impact on our business Something will happen: Legislation, in some form, will be enacted which will attempt to cover the uninsured and lower costs. This may or may not be considered true reform. We are deeply involved: While no one can yet pred
Slide 6: Financial and ethical catalysts for change will lead to legislative change in the U.S.
The financial and ethical catalysts for change will lead to some form of legislative change in the U.S. Financial catalysts Ethical catalysts U.S. spent US$2 trillion in 2007 - US$7,421 / person 47 million uninsured (15% of population) U.S. spends 16.2% of GDP on healthcare; Aging population
Slide 7: The potential impact of healthcare reform and other related legislation
The potential impact of healthcare reform and other related legislation Potential action Impact Coverage for 47 million uninsured Hospitals reimbursement benefit estimated at Hospitals offer US$155 billion to help fund US$16 billion (above savings offered) Bundled payments, readmission penal
Slide 8: Impact on market and on our business
Impact on market and on our business Impact on market volume Siemens position of strength Healthcare IT spending will ramp up once definitions/criteria are established We are actively engaged in discussions and well positioned to respond quickly Installed base unlikely to shrink Healthcare IT
Slide 9: Market position aligned with segments less affected under proposed reform
Market position is well aligned with segments less affected under proposed reform measures Impact of healthcare reform Siemens market share Gain from increased efficiency, 50% Large demand, increased reimbursement hospitals Take up volume from smaller hospitals Medium-size Need to maintain cri
Slide 10: Outperforming in a fast growing market
Outperforming in a fast growing market Opportunities in China © Siemens AG 2009. All rights reserved. Page 10 Sept. 29, 2009 Capital Market Day Healthcare Healthcare Workflow & Solutions
Slide 11: China presents sustained opportunity for growth
China presents sustained opportunity for growth Rapidly growing market: Annual growth rate of ~10%.. Third largest medical imaging market: Expected to surpass Japan within 5 years, fueled by demographics and government initiatives. We grow faster than market: And we are particularly well-posit
Slide 12: The Chinese market is set for continued growth
The Chinese market is set for continued growth HC spending as % of GDP Macro healthcare environment 5.5% 5.6% Aging demographics: 8.1% of population is 3.7% 3.5% 65 years old over (2009 estimate); aging at high speed Growing healthcare market due to increases in cardiovascular disease, cancer, a
Slide 13: We outperform the market in China
We outperform the market in China China market (revenue) Market +10% p.a. growth • Historic Siemens revenue growth double digit • Outperforming the market FY 2008 FY 2011E Volume and market share development: FY 2006 - FY 2008 Total +12% +3% +4% +4% +4% +3% +3% +4% +1% +2% #1 #1 #3 #1 #2 #3 #1 #1 #4
Slide 14: Siemens is well positioned in the high-end market in China
Siemens is well positioned in the high-end market in China Large multi-million projects China Ministry of Health No.1 provider in national bidding for PET-CT Weikang Medical Group Strategic partnership on Imaging and Diagnostics with the first private top hospital in North China Shanghai's first cla
Slide 15: In the Chinese high-end market, our integrated approach is well received
In the Chinese high-end market, our integrated approach is well received Imaging equipment Healthcare IT and PACS Diagnostics Sino-German Friendship Hospital: To be established in the Shanghai International Medical Zone Joint-venture contract signing witnessed by Planned in Shanghai's new Chinese pr
Slide 16: The 'trickle-down' effect enables expansion across all market segments
The 'trickle-down' effect enables Siemens to expand presence across all market segments Leading medical Cutting-edge technology solutions institutions Focus: Medical innovation Strong local presence Broad diagnostic / therapy solutions portfolio Medium / large-size urban hospitals Focus: Advanced Un
Slide 17: Trickle-down effect with expansion of rural healthcare clinics
The trickle-down effect is taking hold with expansion of rural healthcare clinics Shaanxi Provincial Hospital Yan'an Luo- Luochuan County Hospital chuan Xi'an Terracotta army SHAANXI Central Township Health Centers in Luochuan County © Siemens AG 2009. All rights reserved. Page 17 Sept. 29, 2009 Cap
Slide 18: Continuously expanding sales and distribution channels
We are continuously expanding our sales and distribution channels Number of Number of distributors sales staff HLJ JL LN XJ IM BJ HEB TJ NX SX SD QH GS SN HEN JS FY FY FY FY FY FY FY FY TB AH 06 07 08 09E 06 07 08 09E HUB SC CQ ZJ JX Sales development GZ HUN FJ distributor business Regional distribu
Slide 19: We are 'at home' in China with manufacturing and R&D centers
We are 'at home' in China with both manufacturing and R&D centers Shanghai R&D site for Siemens entry-level CT Scope: X-ray tubes for global entry Wuxi and mid range market 2008: SMMR 1st manufacturer in China of a superconducting 1.5T Shenzhen magnet system for the world market 10 year anni
Slide 20: Siemens Healthcare Global Presence, Regional Focus
Siemens Healthcare Global Presence, Regional Focus © Siemens AG 2009. All rights reserved. Page 20 Sept. 29, 2009 Capital Market Day Healthcare Healthcare Workflow & Solutions
Slide 21: Safe Harbour Statement
Safe Harbour Statement This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified by words such as “expects,” “looks forward to,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,”
Slide 22: Reconciliation and Definitions for Non-GAAP Measures (I)
Reconciliation and Definitions for Non-GAAP Measures (I) To supplement Siemens’ Consolidated Financial Statements presented in accordance with International Financial Reporting Standards, or IFRS, Siemens presents the following supplemental financial measures: New orders; Adjusted or organic gro
Slide 23: Reconciliation and Definitions for Non-GAAP Measures (II)
Reconciliation and Definitions for Non-GAAP Measures (II) Adjusted or organic growth rates of Revenue and new orders In its financial reports, Siemens presents, on a worldwide basis and for each Sector and Cross-Sector Business, the percentage change from period to period in Revenue and new orders a
Slide 24: Reconciliation and Definitions for Non-GAAP Measures (III)
Reconciliation and Definitions for Non-GAAP Measures (III) ROCE at the Siemens group level, on a continuing operations basis Siemens also presents group ROCE on a continuing operations basis. For this purpose, the numerator is Income from continuing operations and the denominator is CE, less Assets
Slide 25: Reconciliation and Definitions for Non-GAAP Measures (IV)
Reconciliation and Definitions for Non-GAAP Measures (IV) Adjusted industrial net debt Siemens defines adjusted industrial net debt as net debt less (1) SFS debt excluding SFS internally purchased receivables; less (2) 50% of the nominal amount of our hybrid bond; plus (3) the funded status of pensi
Slide 26: Siemens investor relations contact data
Siemens investor relations contact data Mariel von Drathen +49-89-636-33780 Munich Office +49-89-636-32474 US Office +1-408-464-2004 Internet: http://www.siemens.com/investorrelations Email: investorrelations@siemens.com Fax: +49-89-636-32830 © Siemens AG 2009. All rights reserved. Page 26 Sept. 29,